DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rituxan (Rituximab) - Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neutropenia (16)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rituxan (Rituximab) where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Rituxan side effects in 81 year old male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-22

Patient: 81 year old male

Reactions: Vision Blurred, Neutropenia, Thrombocytopenia, Fall, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in

Reported by a physician from Italy on 2012-07-23

Patient:

Reactions: Neutropenia, Respiratory Tract Infection

Drug(s) suspected as cause:
Cladribine
    Dosage: for 5 consecutive days administered monthly for 4 cycles
    Indication: Waldenstrom's Macroglobulinaemia

Rituxan
    Dosage: on day 1 administered monthly for 4 cycles by infusion
    Indication: Waldenstrom's Macroglobulinaemia



Possible Rituxan side effects in

Reported by a physician from Japan on 2012-07-17

Patient:

Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: B-Cell Lymphoma

Rituxan
    Dosage: 6 doses-2 days prior to each cycle of chop
    Indication: B-Cell Lymphoma

Prednisolone
    Indication: B-Cell Lymphoma

Vincristine
    Indication: B-Cell Lymphoma

Cyclophosphamide
    Indication: B-Cell Lymphoma

Neupogen
    Indication: B-Cell Lymphoma



Possible Rituxan side effects in male

Reported by a physician from Germany on 2012-07-10

Patient: male

Reactions: Neutropenia, Lymphocytic Infiltration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta
    Dosage: 6 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-20
    End date: 2012-04-20

Doxorubicin HCL
    Dosage: 100 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Vincristine
    Dosage: 2 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Cyclophosphamide
    Dosage: 1500 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-17
    End date: 2012-04-17

Rituxan
    Dosage: 750 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-16
    End date: 2012-04-16

Prednisolone
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2012-04-16
    End date: 2012-04-21

Other drugs received by patient: Morphine Sulfate; Acyclovir; Metoclopramide; Dipyrone TAB; Pantoprazole



Possible Rituxan side effects in 54 year old male

Reported by a pharmacist from Canada on 2012-07-10

Patient: 54 year old male

Reactions: White Blood Cell Count Decreased, Peritonitis Bacterial, Hypotension, Hernial Eventration, Neutropenia, Septic Shock, Respiratory Distress, Loss of Consciousness

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Product Used FOR Unknown Indication

Vincristine Sulfate
    Indication: Product Used FOR Unknown Indication

Rituxan
    Indication: Product Used FOR Unknown Indication

Doxorubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Fluconazole; Furosemide; Nadolol; Omeprazole; Amiloride Hydrochloride; Ciprofloxacin; Acyclovir; Lactulose



Possible Rituxan side effects in 43 year old female

Reported by a pharmacist from Canada on 2012-07-09

Patient: 43 year old female, weighing 112.0 kg (246.4 pounds)

Reactions: Oral Candidiasis, Herpes Simplex, Mouth Ulceration, Oropharyngeal Pain, Neutropenia, Neoplasm

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in male

Reported by a pharmacist from United States on 2012-05-21

Patient: male

Reactions: Neutropenia

Drug(s) suspected as cause:
Rituxan

Treanda



Possible Rituxan side effects in 54 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10

Patient: 54 year old male, weighing 91.9 kg (202.2 pounds)

Reactions: Asthma, Dyspnoea, Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 20 milligram
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-25

Revlimid
    Dosage: 20 milligram
    Administration route: Oral
    Start date: 2011-08-17

Rituxan
    Dosage: 375 milligram/sq. meter
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-25

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Other drugs received by patient: Potassium Chloride; Simvastatin; Altace; Zofran; Albuterol; Acidophilus; Zocor; Glucosamine; Insulin; Ultram; Tramadol Hydrochloride; Aspirin; Ciprofloxacin; Hydrochlorothiazide; Ondansetron; Visine EYE Drops; Calcium + Vitamin D; Ondansetron; Ramipril; Humalog; Tessalon; Steroid; Toradol; Singulair; Multi-Vitamins; Novolog; Steroid



Possible Rituxan side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-02

Patient: female

Reactions: Vomiting, Nausea, Anaemia, Constipation, Death, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in 25 year old female

Reported by a pharmacist from Canada on 2012-04-27

Patient: 25 year old female

Reactions: Vomiting, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Indication: Product Used FOR Unknown Indication

Prednisone
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Indication: Product Used FOR Unknown Indication

Neulasta
    Dosage: 6 mg, unk
    Indication: Product Used FOR Unknown Indication

Rituxan
    Indication: Product Used FOR Unknown Indication

Doxorubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Docusate Sodium; Methotrexate; Nabilone; Allopurinol; Oxycodone HCL; Lactulose; Prevacid



Possible Rituxan side effects in 63 year old female

Reported by a pharmacist from Canada on 2012-04-10

Patient: 63 year old female

Reactions: Pneumocystis Jiroveci Pneumonia, Respiratory Failure, Neutropenia, Cognitive Disorder, Thrombocytopenia, Leukopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Rituxan
    Dosage: (the patient received rituximab on 13 january 2012).
    Start date: 2011-12-30

Rituxan
    Dosage: (the patient received rituximab on 21 july 2011, 25 july 2011 and 27 july 2011).
    Indication: Epstein-Barr Virus Infection
    Start date: 2011-07-19

Other drugs received by patient: Proctosone; Cefazolin; Ceftazidime; Albuterol; Primaquine; Levofloxacin; Lansoprazole; Piperacillin and Tazobactam; Nabilone; Prednisone TAB; Hydromorphone HCL; Ipratropium Bromide; Clindamycin; Nystatin; Solu-Medrol



Possible Rituxan side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15

Patient: male, weighing 77.4 kg (170.3 pounds)

Reactions: Abdominal Pain, Economic Problem, Refusal of Treatment by Patient, Anaemia Haemolytic Autoimmune, Burkitt's Lymphoma, Metastases To Pelvis, Ascites, Treatment Related Secondary Malignancy, Chronic Lymphocytic Leukaemia Recurrent, Metastases To Peritoneum, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 600 mg/m2 on weeks 1,5,9,13,17 and 21, (unknown) intravenous (not otherwise specified)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-06-16
    End date: 2008-11-17

Rituxan
    Dosage: 375 mg/m2 over 4 hr/on one day on weeks 1, 5, 9, 13,17 and 21 (unknown) intravenous (not otherwise s
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-06-16
    End date: 2008-11-17

Pentostatin
    Dosage: 4mg/m2 x 1 day weeks 1,5,9,13,17 and 21, (unknown) intravenous (not otherwise specified)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-06-16
    End date: 2008-11-17



Possible Rituxan side effects in 83 year old female

Reported by a consumer/non-health professional from United States on 2012-03-09

Patient: 83 year old female

Reactions: Neutropenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Rituxan



Possible Rituxan side effects in female

Reported by a physician from United Kingdom on 2012-02-27

Patient: female, weighing 84.5 kg (185.9 pounds)

Reactions: Diarrhoea, Mouth Ulceration, Neutropenic Sepsis, Lymphopenia, Anaemia, Pyrexia, Neutropenia, Lethargy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Rituxan

Vincristine
    Indication: B-Cell Lymphoma

Cyclophosphamide
    Indication: B-Cell Lymphoma

Rituxan
    Indication: B-Cell Lymphoma
    Start date: 2010-05-20

Prednisolone
    Indication: B-Cell Lymphoma

Other drugs received by patient: Acetaminophen; Chlorpheniramine Maleate; Cotrim



Possible Rituxan side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02

Patient: 31 year old male

Reactions: Pneumonia, Syncope, Fatigue, Anaemia, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: 420 mg, unk
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma

Rituxan
    Dosage: 788 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Doxorubicin HCL
    Dosage: 103 mg, unk
    Indication: non-Hodgkin's Lymphoma

Neulasta
    Dosage: 6 mg, unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 6.3 g, unk
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: 618 mg, unk
    Indication: non-Hodgkin's Lymphoma

Leucovorin Sodium
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Mesna
    Dosage: 1236 mg, unk
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Dosage: 40 mg, unk
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Ciprofloxacin; Valtrex; Medrol; Fluconazole; Voriconazole; Protonix



Possible Rituxan side effects in 48 year old female

Reported by a physician from United States on 2011-10-28

Patient: 48 year old female

Reactions: Renal Failure, Nausea, Mouth Ulceration, Anaemia, Squamous Cell Carcinoma of Skin, Neutropenia, Rash, Accidental Exposure

Drug(s) suspected as cause:
Dapsone
    Dosage: titrated up to 100 mg twice daily, titrated up to 50 mg daily
    Indication: Behcet's Syndrome

Arava
    Dosage: 20 mg daily
    Indication: Behcet's Syndrome

Imuran
    Dosage: titrated up to 150 mg daily
    Indication: Behcet's Syndrome

Plaquenil
    Dosage: 300 mg daily, 200 mg daily, 200 mg twice daily, oral
    Administration route: Oral
    Indication: Behcet's Syndrome

Enbrel
    Dosage: 25 mg twice weekly
    Indication: Behcet's Syndrome

Methotrexate
    Dosage: 7.5 mg per week, titrated up to 20 mg per week
    Indication: Behcet's Syndrome

Cytoxan
    Dosage: 250 mg, 250 mg, 500 mg, 750 mg, 1000 mg, 1250 mg, intravenous
    Indication: Behcet's Syndrome

Cyclosporine
    Indication: Behcet's Syndrome
    End date: 2001-01-06

Remicade
    Dosage: 200 mg, 300 mg, 400 mg, intravenous
    Indication: Behcet's Syndrome

Leukeran
    Dosage: titrated up to 4 mg daily, 3 mg daily, 3 mg daily
    Indication: Behcet's Syndrome

Colchicine
    Dosage: 6 mg twice daily, 6 mg twice daily
    Indication: Behcet's Syndrome

Cellcept
    Dosage: 1000 mg twice daily
    Indication: Behcet's Syndrome

Rituxan
    Dosage: 1000 mg, 1000 mg, intravenous
    Indication: Behcet's Syndrome
    End date: 2006-07-05

Prednisone
    Dosage: 10 mg daily
    Indication: Behcet's Syndrome

Other drugs received by patient: Terbutaline Sulfate; (Esomeprazole); Pregabalin; Acyclovir; (Fentanyl); Erythromycin; Sertraline Hydrochloride; Theophylline; Pentoxifylline; Furosemide; Folic Acid; Fluticasone Propionate / Salmeterol; Ipratropium Bromide and Albuterol Sulfate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014